Risimtinib

Overview

Risimtinib (Risimtinibum) is a FGFR1 inhibitor with an IC 50 of 2.1 nM. Risimtinib inhibits the proliferation of FGFR1-positive cancer cells. Risimtinib is used for the research of myeloid leukemia.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > Acute Myeloid Leukemia | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer | Products > Signaling Pathways > FGFR

Product Information

• Catalog No.: HY-184094
• CAS No.: 2126751-11-7
• Molecular Formula: C30H31N5O3
• Molecular Weight: 509.60
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source